Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin

Biochimica et Biophysica Acta - General Subjects

Volumn 1830, Issue 6, 2013, Pages 3427-3436

  Sánchez Vásquez, Lorenzo ^a   Silva Sanchez, Jesus ^b   Jiménez Vargas, Juana Maria ^a   Rodríguez Romero, Adela ^c   Muñoz Garay, Carlos ^a   Rodríguez, Maria C ^b   Gurrola, Georgina B ^a   Possani, Lourival D ^a  

^a INSTITUTO DE BIOTECNOLOGÍA   (Mexico)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Antibiotic; Antimicrobial peptide; Calcein release; Cell viability; MDR clinical isolate; Plasmodium berghei

Indexed keywords

GLYCYLISOLEUCYLLEUCYLLYSYLTHREONYLISOLEUCYLLYSYLSERYLISOLEUCYLALANYLSERYLLYSYLVANYLALANYLASPARGINYLTHREONYLVALYLGLUTAMYLLYSYLLEUCYLLYSYLARGINYLLYSYLALANYLLYSYLASPARGINYLALANYLVALYLALANINE DELTA[1 GLYCINE 11 SERINE 29 ALANINE]; GLYCYLISOLEUCYLLEUCYLLYSYLTHREONYLISOLEUCYLLYSYLSERYLISOLEUCYLALANYLSERYLLYSYLVANYLALANYLASPARGINYLTHREONYLVALYLGLUTAMYLLYSYLLEUCYLLYSYLARGINYLLYSYLALANYLLYSYLASPARGINYLALANYLVALYLALANINE DELTA[1 GLYCINE 11 SERINE]; GLYCYLISOLEUCYLLEUCYLLYSYLTHREONYLISOLEUCYLLYSYLSERYLISOLEUCYLALANYLSERYLLYSYLVANYLALANYLASPARGINYLTHREONYLVALYLGLUTAMYLLYSYLLEUCYLLYSYLARGINYLLYSYLALANYLLYSYLASPARGINYLALANYLVALYLALANINE DELTA[1 GLYCINE 18 GLUTAMINE 29 ALANINE]; GLYCYLISOLEUCYLLEUCYLLYSYLTHREONYLISOLEUCYLLYSYLSERYLISOLEUCYLALANYLSERYLLYSYLVANYLALANYLASPARGINYLTHREONYLVALYLGLUTAMYLLYSYLLEUCYLLYSYLARGINYLLYSYLALANYLLYSYLASPARGINYLALANYLVALYLALANINE DELTA[1 GLYCINE 18 GLUTAMINE]; GLYCYLISOLEUCYLLEUCYLLYSYLTHREONYLISOLEUCYLLYSYLSERYLISOLEUCYLALANYLSERYLLYSYLVANYLALANYLASPARGINYLTHREONYLVALYLGLUTAMYLLYSYLLEUCYLLYSYLARGINYLLYSYLALANYLLYSYLASPARGINYLALANYLVALYLALANINE DELTA[1 GLYCINE 5 THREONINE 29 ALANINE]; GLYCYLISOLEUCYLLEUCYLLYSYLTHREONYLISOLEUCYLLYSYLSERYLISOLEUCYLALANYLSERYLLYSYLVANYLALANYLASPARGINYLTHREONYLVALYLGLUTAMYLLYSYLLEUCYLLYSYLARGINYLLYSYLALANYLLYSYLASPARGINYLALANYLVALYLALANINE DELTA[1 GLYCINE 5 THREONINE]; GLYCYLISOLEUCYLLEUCYLLYSYLTHREONYLISOLEUCYLLYSYLSERYLISOLEUCYLALANYLSERYLLYSYLVANYLALANYLASPARGINYLTHREONYLVALYLGLUTAMYLLYSYLLEUCYLLYSYLARGINYLLYSYLALANYLLYSYLASPARGINYLALANYLVALYLALANINE DELTA[1 GLYCINE 8 SERINE 29 ALANINE]; GLYCYLISOLEUCYLLEUCYLLYSYLTHREONYLISOLEUCYLLYSYLSERYLISOLEUCYLALANYLSERYLLYSYLVANYLALANYLASPARGINYLTHREONYLVALYLGLUTAMYLLYSYLLEUCYLLYSYLARGINYLLYSYLALANYLLYSYLASPARGINYLALANYLVALYLALANINE DELTA[1 GLYCINE 8 SERINE]; GLYCYLISOLEUCYLLEUCYLLYSYLTHREONYLISOLEUCYLLYSYLSERYLISOLEUCYLALANYLSERYLLYSYLVANYLALANYLASPARGINYLTHREONYLVALYLGLUTAMYLLYSYLLEUCYLLYSYLARGINYLLYSYLALANYLLYSYLASPARGINYLALANYLVALYLALANINE DELTA[12 LYSINE 18 GLUTAMINE 26 ASPARGININE 29 ALANINE]; GLYCYLISOLEUCYLLEUCYLLYSYLTHREONYLISOLEUCYLLYSYLSERYLISOLEUCYLALANYLSERYLLYSYLVANYLALANYLASPARGINYLTHREONYLVALYLGLUTAMYLLYSYLLEUCYLLYSYLARGINYLLYSYLALANYLLYSYLASPARGINYLALANYLVALYLALANINE DELTA[29 ALANINE]; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; AMINO ACID SEQUENCE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ANTIPARASITIC ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SCREENING; ENTEROBACTER CLOACAE; ERYTHROCYTE; ESCHERICHIA COLI; EUKARYOTIC CELL; GROWTH INHIBITION; HOSPITAL INFECTION; HUMAN; HUMAN CELL; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PLASMODIUM BERGHEI; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMALARIALS; CERCOPITHECUS AETHIOPS; COS CELLS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; HEK293 CELLS; HUMANS; MICE; MICE, INBRED BALB C; PEPTIDES; PLASMODIUM BERGHEI; SCORPION VENOMS; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); EUKARYOTA; NEGIBACTERIA; PLASMODIUM BERGHEI; POSIBACTERIA; SCORPIONES; STAPHYLOCOCCUS AUREUS;

EID: 84875996921     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.01.028     Document Type: Article

References (55)

1. P.M. Hawkey, and A.M. Jones The changing epidemiology of resistance J. Antimicrob. Chemother. 64 Suppl. 1 2009 i3 i10
2. L.B. Rice The clinical consequences of antimicrobial resistance Curr. Opin. Microbiol. 12 2009 476 481
3. B. Spellberg, R. Guidos, D. Gilbert, J. Bradley, H.W. Boucher, W.M. Scheld, J.G. Bartlett, and J. Edwards Jr. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America Clin. Infect. Dis. 46 2008 155 164
4. A. Torres-Larios, G.B. Gurrola, F.Z. Zamudio, and L.D. Possani Hadrurin, a new antimicrobial peptide from the venom of the scorpion Hadrurus aztecus Eur. J. Biochem. 16 2000 5023 5031
5. H. Powers Bad Bugs, No Drugs: As Antibiotic Discovery Stagnates. A Public Health Crisis Brews 2004 Infectious Disease Society of America Arlington, VA 1 37
6. Y. Chen, A.I. Vasil, L. Rehaume, C.T. Mant, J.L. Burns, M.L. Vasil, R.E.W. Hancock, and R.S. Hodges Comparison of biophysical and biologic properties of alpha-helical enantiomeric antimicrobial peptides Chem. Biol. Drug Des. 67 2006 162 173
7. J. Silva, C. Aguilar, G. Ayala, M.A. Estrada, U. Garza-Ramos, R. Lara-Lemus, and L. Ledezma TLA-1: a new plasmid-mediated extended-spectrum beta-lactamase from Escherichia coli Antimicrob. Agents Chemother. 44 2000 997 1003
8. B.M. Peters, M.E. Shirtliff, and M.A. Jabra-Rizk Antimicrobial peptides: primeval molecules or future drugs? PLoS Pathog. 6 10 2010 e1001067
9. J.D.F. Hale, and R.E.W. Hancock Alternative mechanisms of action of cationic antimicrobial peptides on bacteria Expert Rev. Anti Infect. Ther. 5 2007 951 959
10. M. Dathe, T. Wieprecht, H. Nikolenko, L. Handel, W.L. Maloy, D.L. MacDonald, M. Beyermann, and M. Bienert Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides FEBS Lett. 403 1997 208 212
11. R.B. Merrifield Solid phase peptide synthesis. I. The synthesis of a tetrapeptide J. Am. Chem. Soc. 85 1963 2149 2154
12. A.R. Koczulla, and R. Bals Antimicrobial peptides: current status and therapeutic potential Drugs 63 2003 389 406
13. K.A. Brogden Nat. Rev. Microbiol. 3 2005 238 250
14. Y. Huang, J. Huang, and Y. Chen Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Protein Cell. 1 2010 143 152
15. A.K. Marr, W.J. Gooderham, and R.E. Hancock Antibacterial peptides for therapeutic use: obstacles and realistic outlook Curr. Opin. Pharmacol. 6 2006 468 472
16. M. Stark, L.P. Liu, and C.M. Deber Cationic hydrophobic peptides with antimicrobial activity Antimicrob. Agents Chemother. 46 2002 3585 3590
17. + permeability changes Toxicon 54 2009 802 817
18. G. Corzo, P. Escoubas, E. Villegas, K.J. Barnham, W. He, R.S. Norton, and T. Nakajima Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator Biochem. J. 359 Pt 1 2001 35 45
19. L. Dai, G. Corzo, H. Naoki, M. Andriantsiferana, and T. Nakajima Purification, structure-function analysis, and molecular characterization of novel linear peptides from scorpion Opisthacanthus madagascariensis Biochem. Biophys. Res. Commun. 293 2002 1514 1522
20. R. Conde, F.Z. Zamudio, M.H. Rodríguez, and L.D. Possani Scorpine, an anti-malaria and anti-bacterial agent purified from scorpion venom FEBS Lett. 471 2001 165 168
21. C.A. Hernández-Aponte, J. Silva-Sanchez, V. Quintero- Hernández, A. Rodríguez-Romero, C. Balderas, L.D. Possani, and G.B. Gurrola Vejovine, a new antibiotic from the scorpion venom of Vaejovis mexicanus Toxicon 57 2011 84 92
22. M.R. Yeaman, and N.Y. Yount Mechanisms of antimicrobial peptide action and resistance Pharmacol. Rev. 55 2003 27 55
23. A.P. Magiorakos, A. Srinivasan, R.B. Carey, Y. Carmeli, M.E. Falagas, C.G. Giske, S. Harbarth, J.F. Hindler, G. Kahlmeter, B. Olsson-Liljequist, D.L. Paterson, L.B. Rice, J. Stelling, M.J. Struelens, A. Vatopoulos, J.T. Weber, and D.L. Monnet Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance Clin. Microbiol. Infect. 18 3 2012 268 281
24. J. Silva, R. Gatica, C. Aguilar, Z. Becerra, U. Garza-Ramos, M. Velázquez, G. Miranda, B. Leaños, F. Solórzano, and G. Echániz Outbreak of infection with extended-spectrum beta-lactamase- producing Klebsiella pneumoniae in a Mexican hospital J. Clin. Microbiol. 39 2001 3193 3196
25. U. Garza-Ramos, R. Morfin-Otero, H.S. Sader, R.N. Jones, E. Hernández, E. Rodriguez-Noriega, A. Sanchez, B. Carrillo, S. Esparza-Ahumada, and J. Silva-Sanchez Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico Antimicrob. Agents Chemother. 52 2008 2943 2946
26. M. Schiffer, and A.B. Edmundson Use of helical wheels to represent the structures of proteins and to identify segments with helical potential Biophys. J. 7 1967 121 135
27. T.D. Wikins, L.V. Holdeman, I.J. Abramson, and W.E. Moore Standardized single-disc method for antibiotic susceptibility testing of anaerobic bacteria Antimicrob. Agents Chemother. 1 1972 451 459
28. M.C. Rodríguez, G. Margos, H. Compton, M. Ku, H. Lanz, M.H. Rodríguez, and R.E. Sinden Plasmodium berghei: routine production of pure gametocytes, extracellular gametes, zygotes, and ookinetes Exp. Parasitol. 101 2002 73 76
29. C. Perez-Iratxeta, and M.A. Andrade-Navarro K2D2: estimation of protein secondary structure from circular dichroism spectra BMC Struct. Biol. 13 2008 8 25
30. F.L. Graham, J. Smiley, W.C. Russell, and R. Nairn Characteristics of a human cell line transformed by DNA from human adenovirus type 5 J. Gen. Virol. 36 1977 59 74
31. F.C. Jensen, A.J. Girardi, R.V. Gilden, and H. Koprowski Infection of human and simian tissue cultures with Rous sarcoma virus Proc. Natl. Acad. Sci. U. S. A. 52 1964 53 59
32. J.A. Plumb Cell sensitivity assays: the MTT assay Methods Mol. Med. 88 2004 165 169
33. T. Wieprecht, O. Apostolov, and J. Seelig Binding of the antibacterial peptide magainin 2 amide to small and large unilamellar vesicles Biophys. Chem. 85 2000 187 198
34. O.S. Belokoneva, E. Villegas, G. Corzo, L. Dai, and T. Nakajima The hemolytic activity of six arachnid cationic peptides is affected by the phosphatidylcholine-to-sphingomyelin ratio in lipid bilayers Biochim. Biophys. Acta 1617 2003 22 30
35. Y. Chen, M.T. Guarnieri, A.I. Vasil, M.L. Vasil, C.T. Mant, and R.S. Hodges Role of peptide hydrophobicity in the mechanism of action of α-helical antimicrobial peptides Antimicrob. Agents Chemother 5 2007 1398 1406
36. E.F. Haney, H.N. Hunter, K. Matsuzaki, and H.J. Vogel Solution NMR studies of amphibian antimicrobial peptides: linking structure to function? Biochim. Biophys. Acta 1788 8 2009 1639 1655
37. N.J. Greenfield Using circular dichroism spectra to estimate protein secondary structure Nat. Protoc. 1 2006 2876 2890
38. W. Fang, J. Vega-Rodríguez, A.K. Ghosh, M. Jacobs-Lorena, A. Kang, and St.R.J. Leger Development of transgenic fungi that kill human malaria parasites in mosquitoes Science 331 2011 1074 1077
39. H.T. Chou, H.W. Wen, T.Y. Kuo, C.C. Lin, and W.J. Chen Interaction of cationic antimicrobial peptides with phospholipid vesicles and their antibacterial activity Peptides 31 2010 1811 1820
40. Z.G. Tian, T.T. Dong, D. Teng, Y.L. Yang, and J.H. Wang Design and characterization of novel hybrid peptides from LFB15(W4,10), HP(2-20), and cecropin A based on structure parameters by computer-aided method Appl. Microbiol. Biotechnol. 82 2009 1097 1103
41. A.A. Langham, H. Khandelia, B. Schuster, A.J. Waring, R.I. Lehrer, and Y.N. Kaznessis Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity Peptides 29 2008 1085 1093
42. T. Tachi, R.F. Epand, R.M. Epand, and K. Matsuzaki Position-dependent hydrophobicity of the antimicrobial magainin peptide affects the mode of peptide-lipid interactions and selective toxicity Biochemistry 41 2002 10723 10731
43. S.H. Lee, S.J. Kim, Y.S. Lee, M.D. Song, I.H. Kim, and H.S. Won De novo generation of short antimicrobial peptides with simple amino acid composition Regul. Pept. 166 2011 36 41
44. R.M. Epand, and R.F. Epand Lipid domains in bacterial membranes and the action of antimicrobial agents Biochim. Biophys. Acta 1788 2009 289 294
45. A.A. Polyansky, A.A. Vassilevski, P.E. Volynsky, O.V. Vorontsova, O.V. Samsonova, N.S. Egorova, N.A. Krylov, A.V. Feofanov, A.S. Arseniev, E.V. Grishin, and R.G. Efremov N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins FEBS Lett. 583 2009 2425 2428
46. W.G. Bessler, M. Huber, and W. Baier Bacterial cell wall components as immunomodulators-II. The bacterial cell wall extract OM-85 BV as unspecific activator, immunogen and adjuvant in mice Int. J. Immunopharmacol. 19 1997 551 558
47. Y. Rosenfeld, and Y. Shai Lipopolysaccharide (Endotoxin)-host defense antibacterial peptides interactions: role in bacterial resistance and prevention of sepsis Biochim. Biophys. Acta 1758 2006 1513 1522
48. S. Rieg, A. Huth, H. Kalbacher, and W.V. Kern Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps Int. J. Antimicrob. Agents 33 2009 174 176
49. S. Kim, S.S. Kim, and B.J. Lee Correlation between the activities of α-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times Peptides 26 2005 2050 2056
50. A. Dagan, L. Efron, L. Gaidukov, A. Mor, and H. Ginsburg In vitro antiplasmodium effects of dermaseptin S4 derivatives Antimicrob. Agents Chemother. 46 2002 1059 1066
51. I. Radzishevsky, M. Krugliak, H. Ginsburg, and A. Mor Antiplasmodial activity of lauryl-lysine oligomers Antimicrob. Agents Chemother. 51 2007 1753 1759
52. B. Gao, J. Xu, M. del C. Rodriguez, H. Lanz-Mendoza, R. Hernández-Rivas, W. Du, and S. Zhu Characterization of two linear cationic antimalarial peptides in the scorpion Mesobuthus eupeus Biochimie. 92 2010 350 359
53. S. Zhu, B. Gao, A. Aumelas, M. del C. Rodríguez, H. Lanz-Mendoza, S. Peigneur, E. Diego-Garcia, M.F. Martin-Eauclaire, J. Tytgat, and L.D. Possani MeuTXKbeta1, a scorpion venom-derived two-domain potassium channel toxin-like peptide with cytolytic activity Biochim. Biophys. Acta. 1804 2010 872 883
54. M.M. Javadpour, M.M. Juban, W.C. Lo, S.M. Bishop, J.B. Alberty, S.M. Cowell, C.L. Becker, and M.L. McLaughlin De novo antimicrobial peptides with low mammalian cell toxicity J. Med. Chem. 39 1996 3107 3113
55. D. Venugopal, D. Klapper, A.H. Srouji, J.B. Bhonsle, R. Borschel, A. Mueller, A.L. Russell, B.C. Williams, and R.P. Hicks Novel antimicrobial peptides that exhibit activity against select agents and other drug resistant bacteria Bioorg. Med. Chem. 18 2010 5137 5147